INT215302
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Moreover, they found that a derotation screw located superior to the SHS did not add any increase in fixation after the SHS is placed. | |||||||||||||||
| |||||||||||||||
|
However, under the assumption that this response bias was independent of SHS exposure, the findings from the analyses assessing the association between SHS exposure and disease would not be affected. | |||||||||||||||
| |||||||||||||||
|
However, under the assumption that this response bias was independent of SHS exposure, the findings from the analyses assessing the association between SHS exposure and disease would not be affected. | |||||||||||||||
| |||||||||||||||
|
Less is known about the potential long-term health consequences experienced by FAs exposed to SHS during the time smoking was allowed on airplanes. | |||||||||||||||
| |||||||||||||||
|
The mean (SD) progression of total SHS was 2.9 (7.6) after four years compared with year one and 14% of the patients had progressive total joint damage of 5 units or more after four years compared with year one. | |||||||||||||||
| |||||||||||||||
|
The mean (SD) cumulative progression of total SHS in hands and feet was 3.0 (11.3), 4.9 (14.5), 5.8 (16.7) and 6.6 (13.3) after one to four years compared with baseline. | |||||||||||||||
| |||||||||||||||
|
The mean (SD) progression of total SHS in hands and feet, and SHS in hands and feet separately was 3.0 (11.3), 1.9 (7.0) and 1.1 (5.0), respectively. | |||||||||||||||
| |||||||||||||||
|
The mean (SD) progression of total SHS in hands and feet, and SHS in hands and feet separately was 3.0 (11.3), 1.9 (7.0) and 1.1 (5.0), respectively. | |||||||||||||||
| |||||||||||||||
|
To explore further the usefulness of progressive joint damage in the first year as a predictor of subsequent progressive damage, joint damage progression in the first year was divided in to four groups: no progression (SHS ? | |||||||||||||||
| |||||||||||||||
|
0 unit, the reference group), dubious progression (0<SHS<5 units), moderate progression (5 ? | |||||||||||||||
| |||||||||||||||
|
SHS<10 units) and high progression (SHS ? | |||||||||||||||
| |||||||||||||||
|
It might be argued whether progression of SHS is useful in clinical practice as a predictor, because it is a complicated scoring method that requires special training to perform. | |||||||||||||||
| |||||||||||||||
|
In patients with hand BMD loss the mean (SD) progression of total SHS after one year was 4.0 (13.6) compared with 1.1 (2.6) in patients without hand BMD loss (P = 0.036 derived by non-parametric test). | |||||||||||||||
| |||||||||||||||
|
SHS<10 units) and high progression (SHS ? | |||||||||||||||
| |||||||||||||||
|
The levels of SHS sub-scales and the scores according to HBI and UC-DAI are shown in box plots, one box per time point measured. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.